Evidence map›Paper›PMID 40741172›Full record

ArticleFrontiers in endocrinology2025

The association between triglyceride glucose-body mass index and overall survival in postoperative patient with lung cancer.

Shanshan Cai, Hongquan Xing, Yihan Wang, Weichang Yang, Hongdan Luo, Xiaoqun Ye

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shanshan CaiDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Hongquan XingDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Yihan WangDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Weichang YangDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Hongdan LuoDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Xiaoqun YeDepartment of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Lung cancer continues to be one of the leading causes of cancer-related mortality, and the identification of effective prognostic markers is crucial for enhancing post-surgical outcomes. The present study was designed to investigate the association between the triglyceride-glucose body mass index (TyG-BMI) and postoperative overall survival (OS) rates in patients undergoing lung cancer surgery, while also evaluating its potential prognostic value for predicting postoperative outcomes. Methods: This study conducted a retrospective look at the data sourced from lung cancer patients undergone surgical procedures at the Second Affiliated Hospital of Nanchang University between 2016 and 2022. By dividing patients by TyG-BMI, the correlation between TyG-BMI and OS was determined via Cox regression modeling, Lasso regression, and Kaplan-Meier survival analyses. The link between TyG-BMI and OS regarding the dose-response was scrutinized by restricted cubic spline (RCS) analysis. A dynamic prognostic nomogram model based on TyG-BMI and other clinical factors was developed and validated. Results: The survival rates showed a significant variation between those with low and high TyG-BMI values, with the low TyG-BMI group having significantly better survival rates (P = 0.012). Multivariate analysis confirmed that smoking, pathological type, lymph node metastasis, N stage, and TyG-BMI were independent prognostic factors for OS. The nomogram model demonstrated robust predictive performance, achieving AUC values of 0.77, 0.81, and 0.86 for predicting OS at 24, 48, and 72 months, respectively, outperforming traditional TNM staging. Calibration and decision curve analyses further confirmed the model's predictive accuracy and clinical utility. Conclusion: TyG-BMI is a valuable prognostic biomarker for assessing survival outcomes in lung cancer patients post-surgery. The predictive model based on TyG-BMI provides a valuable tool for the prognosis assessment of lung cancer. These findings need to be further validated, and the potential mechanism between TyG-BMI and lung cancer prognosis needs to be further investigated.

Indexed as

Blood GlucoseBody Mass IndexLung NeoplasmsTriglyceridesAdultAgedFemaleHumansMaleMiddle AgedNomogramsPostoperative PeriodPrognosisRetrospective StudiesSurvival RateBlood GlucoseTriglyceridesdynamic nomogramlung canceroverall survivalprognostic biomarkerTyG-BMI

Identifiers

PMID40741172
PMCPMC12307163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.